Federal contract award
75P00121F37011
FAPS CALL 23 FDA ACCOUNTING SERVICES AND FINANCIAL MANAGEMENT SUPPORT
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | PROGRAM SUPPORT CENTER ACQ MGMT SVC |
| NAICS | 541211 — Offices of Certified Public Accountants |
| PSC | R710 — Financial Services (includes credit card services and any other financial services. See revision to description for code R703 above) |
| Parent award / vehicle | 75P00119A00028 |
| Set-aside | Not reported |
| Pricing type | TIME AND MATERIALS |
| Obligations | $3.0M |
| Current contract value | $3.0M |
| Potential contract value / ceiling | $3.0M |
| Start date | Sep 15, 2021 |
| Current end date | Sep 14, 2026 |
| Potential end date | Sep 14, 2026 |
| Latest award activity | Sep 12, 2025 |
| Source loaded | Sep 26, 2026 |
Funding and modification history
Showing the latest 7 of 7 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Sep 12, 2025 | P00006 | $590.6K | MODIFICATION TO EXERCISE OPTION FAPS CALL 23 FDA ACCOUNTING SERVICES AND FINANCIAL MANAGEMENT SUPPORT |
| Sep 10, 2024 | P00005 | $580.2K | FAPS CALL 23 FDA ACCOUNTING SERVICES AND FINANCIAL MANAGEMENT SUPPORT |
| Sep 5, 2024 | P00004 | $74.7K | FAPS CALL 23 FDA ACCOUNTING SERVICES AND FINANCIAL MANAGEMENT SUPPORT |
| Sep 14, 2023 | P00003 | $569.9K | FAPS CALL 23 FDA ACCOUNTING SERVICES AND FINANCIAL MANAGEMENT SUPPORT |
| Mar 9, 2023 | P00002 | $0 | FAPS CALL 23 FDA ACCOUNTING SERVICES AND FINANCIAL MANAGEMENT SUPPORT |
| Sep 13, 2022 | P00001 | $599.9K | FAPS CALL 23 FDA ACCOUNTING SERVICES AND FINANCIAL MANAGEMENT SUPPORT |
| Jul 29, 2021 | 0 | $549.9K | FAPS CALL 23 FDA ACCOUNTING SERVICES AND FINANCIAL MANAGEMENT SUPPORT |
Research next steps
- Confirm the ordering vehicle and your eligibility or a qualified teaming route.
- Review the award scope and buyer evidence before making a bid/no-bid decision.